GGrantIndex
Sort

16,179 grants matching malaria

Cellular and Molecular Physiology of Bloodstream Malaria Parasites

$1,277,294
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Malaria parasite and vector genomics: transmission, pathology, and therapeutics

$1,273,577
Daniel E Neafsey · Broad Institute, Inc. · U19 · FY2015 · AI

India International Center for Excellence in Research

$1,272,313
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Natl Resource for Mass Spectrom of Biolog Macromolecules

$1,271,345
Brian T Chait · Rockefeller University · P41 · FY2006 · RR

Design Of Immunogens

$1,269,871
Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Mechanisms Of Humoral Evasion

$1,269,871
Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

PurSUiT: Untangling a clade of inter-dependent apicomplexans and their bacterial endosymbionts.

$1,269,344
Christopher E Lane · University Of Rhode Island · · FY2023 · BIO

AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAM

$1,268,163
Weill Medical College Of Cornell Univ · D43 · FY2002 · TW

Malaria Evolution in South Asia

$1,268,015
Pradipsinh K. Rathod · University Of Washington · U19 · FY2017 · AI

Treating Brain Swelling in Pediatric Cerebral Malaria

$1,267,352
Terrie Ellen Taylor · Michigan State University · U01 · FY2022 · AI

The Initiation of B-Cell Signaling

$1,265,961
Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Amazonian Center of Excellence in Malaria Research

$1,263,688
Joseph M. Vinetz · University Of California, San Diego · U19 · FY2017 · AI

Southeast Asia Malaria Research Center

$1,262,650
Liwang Cui · Pennsylvania State University, The · U19 · FY2017 · AI

ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)

$1,261,890
University Of Alabama At Birmingham · U01 · FY2003 · AI

Novel Tetracycyclines as Antimalarial Drugs

$1,261,780
Paratek Pharmaceuticals · R42 · FY2005 · AI

Malaria Transmission Blocking Vaccine Discovery

$1,261,623
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru

$1,261,366
Michelle Sang Hsiang · University Of California, San Francisco · U01 · FY2023 · AI

Malaria Vaccine: BSAM

$1,260,732
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Malaria Vaccine: AMA1-C1

$1,260,732
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Malaria Pathogenesis in Pregnant Women and Young Children

$1,260,350
Michal Fried · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses

$1,258,384
Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Structure and function of eukaryotic DNA transposases

$1,257,643
Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal

$1,257,243
Matthew G Dorsey · University Of California, San Francisco · U19 · FY2019 · AI

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection

$1,254,541
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site

$1,254,364
Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI